ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Freshpet (NASDAQ:FRPT) Misses Q2 Sales Targets

FRPT Cover Image

Pet food company Freshpet (NASDAQ: FRPT) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 12.5% year on year to $264.7 million. Its GAAP profit of $0.33 per share was significantly above analysts’ consensus estimates.

Is now the time to buy Freshpet? Find out by accessing our full research report, it’s free.

Freshpet (FRPT) Q2 CY2025 Highlights:

  • Revenue: $264.7 million vs analyst estimates of $268.8 million (12.5% year-on-year growth, 1.5% miss)
  • EPS (GAAP): $0.33 vs analyst estimates of $0.09 (significant beat)
  • Adjusted EBITDA: $44.4 million vs analyst estimates of $38.93 million (16.8% margin, 14.1% beat)
  • EBITDA guidance for the full year is $200 million at the midpoint, above analyst estimates of $193.9 million
  • Operating Margin: 6.7%, up from -0.7% in the same quarter last year
  • Free Cash Flow was $445,000, up from -$5.91 million in the same quarter last year
  • Organic Revenue was up 12.5% year on year
  • Sales Volumes rose 10.8% year on year (28.3% in the same quarter last year)
  • Market Capitalization: $3.21 billion

"Against a more challenging consumer sentiment backdrop, we continue to significantly outperform the dog food category - delivering both category leading sales growth and strong improvements in operations," commented Billy Cyr, Freshpet’s Chief Executive Officer.

Company Overview

Standing out from typical processed pet foods, Freshpet (NASDAQ: FRPT) is a pet food company whose product portfolio includes natural meals and treats for dogs and cats.

Revenue Growth

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul.

With $1.04 billion in revenue over the past 12 months, Freshpet is a small consumer staples company, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and negotiating leverage with retailers. On the bright side, it can grow faster because it has a longer list of untapped store chains to sell into.

As you can see below, Freshpet’s 27.7% annualized revenue growth over the last three years was exceptional as consumers bought more of its products.

Freshpet Quarterly Revenue

This quarter, Freshpet’s revenue grew by 12.5% year on year to $264.7 million but fell short of Wall Street’s estimates.

Looking ahead, sell-side analysts expect revenue to grow 15.6% over the next 12 months, a deceleration versus the last three years. Still, this projection is admirable and indicates the market is forecasting success for its products.

Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend.

Volume Growth

Revenue growth can be broken down into changes in price and volume (the number of units sold). While both are important, volume is the lifeblood of a successful staples business as there’s a ceiling to what consumers will pay for everyday goods; they can always trade down to non-branded products if the branded versions are too expensive.

Freshpet’s average quarterly volume growth of 21.9% over the last two years has beaten the competition by a long shot. This is great because companies with significant volume growth are needles in a haystack in the stable consumer staples sector. Freshpet Year-On-Year Volume Growth

In Freshpet’s Q2 2025, sales volumes jumped 10.8% year on year. This result was a meaningful deceleration from its historical levels. We’ll be watching Freshpet closely to see if it can reaccelerate demand for its products.

Key Takeaways from Freshpet’s Q2 Results

We were impressed by how significantly Freshpet blew past analysts’ EPS expectations this quarter. We were also excited its EBITDA outperformed Wall Street’s estimates by a wide margin. On the other hand, its gross margin missed and its organic revenue fell short of Wall Street’s estimates. Overall, this print was mixed but still had some key positives. The stock traded up 1.9% to $67.11 immediately following the results.

Freshpet had an encouraging quarter, but one earnings result doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here, it’s free.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.